0.00Open0.32Pre Close0 Volume39 Open Interest22.50Strike Price0.00Turnover71.87%IV32.37%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.32Extrinsic Value100Contract SizeAmericanOptions Type0.0764Delta0.0459Gamma53.88Leverage Ratio-0.0093Theta0.0008Rho4.12Eff Leverage0.0062Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet